Robert Rosen, President at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 176,328 shares at $23.47 ($4.1M) on 2016-04-19, disclosed to the SEC on 2016-04-21.
Open-market sale of $4.1M HRTX by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.50 | 60,925 | $1.4M | 33.3% |
| 2 | $23.47 | 76,949 | $1.8M | 43.8% |
| 3 | $24.49 | 32,224 | $789K | 19.1% |
| 4 | $25.11 | 6,230 | $156K | 3.8% |
| Total | $23.38 avg | 176,328 | $4.1M | 100% |
| Filing → |
| HRTX | SELL | 2016-08-12 | $2.3M | — | Filing → |
| HRTX | SELL | 2016-04-21 | $436K | — | Filing → |
| HRTX | SELL | 2016-04-21 | $2.3M | — | Filing → |